Company news
PureTech Health PLC news in 2023
PureTech Health PLC's news releases, calls and decks from 2023, newest first.
BMY Acquires PRTC Founded Entity Karuna for $14B
December 22, 2023
PRTC Year End Update & Outlook for 2024
December 20, 2023
New LYT-200 Solid Tumors Data Presented at ESMO-IO
December 7, 2023
PRTC: Karuna's NDA for KarXT Accepted by U.S. FDA
November 29, 2023
Karuna's Blood Pressure Trial of KarXT Successful
November 17, 2023
PRTC Achieves Primary Endpoint in Anxiety Trial
November 14, 2023
PRTC to Present at Upcoming Conferences + Progress
October 17, 2023
New LYT-100 Data from Phase 1 Trials at Conference
October 11, 2023
Vedanta VE202 Ph2 Starts + Fast Track Designation
October 4, 2023
KarXT-invented at PRTC-submitted for FDA Approval
September 28, 2023
PRTC Names Robert Lyne as Chief Portfolio Officer
September 27, 2023
PRTC Gets $11.4M Grant for Ph2 of LYT-300 in FXTAS
August 1, 2023
PureTech Begins Ph2a Trial of LYT-300 for anxiety
June 21, 2023
Akili Releases EndeavorOTC - Adult ADHD Treatment
June 7, 2023
PureTech to Present at Jefferies Healthcare Conf
May 24, 2023
New Sonde Study: Vocal Biomarkers for Respiratory
May 23, 2023
Vedanta Fast Track Designation & Ph2 Data at DDW
May 9, 2023
Akili Trial Results of EndeavorRx in Adults w/ADHD
May 4, 2023
PRTC Final Results & Publication of Annual Report
April 28, 2023
Vedanta Gets $106M+ to Advance Microbiome Pipeline
April 25, 2023
Vedanta Publishes VE303 Phase 2 Results in JAMA
April 17, 2023
PRTC Gets Up To $500M From RPRX For KarXT Royalty
March 23, 2023
Karuna 2nd Successful Ph3 Study in Schizophrenia
March 20, 2023
PureTech to Present at Barclays Healthcare Conf
March 1, 2023
Sonde & MGH Lead Study on Frontotemporal Disorders
February 27, 2023
PRTC Plans Ph2a trials w/ LYT-300 in PPD/Anxiety
February 14, 2023
PureTech to Present at SVB Global Biopharma Conf.
February 1, 2023
AKLI Positive ADHD Pivotal Data in Kids 13-17 yrs
January 6, 2023